Skip to main content
. Author manuscript; available in PMC: 2023 Apr 2.
Published in final edited form as: Ann Rheum Dis. 2022 Mar 25;81(8):1143–1150. doi: 10.1136/annrheumdis-2022-222168

Table 2.

ANA inter-test percentage agreement among IFA1 (n=805), IFA2 (n=805), and ELISA (n=805)

Enrolment (%) Year 3 (%) Year 5 (%)
IFA1 IFA2 IFA1 IFA2 IFA1 IFA2
IFA2 96.4% (94.9 –97.6) 95.2% (93.4–96.5) 95.5% (93.9–96.8)
ELISA 94.8% (93.0–96.2) 95.7% (94.0–97.0) 91.2% (89.0–93.0) 92.5% (90.5–94.3) 91.4% (89.3–93.3) 91.2% (89.0–93.0)

Abbreviations: ANA, anti-nuclear antibodies; ELISA, enzyme-linked immunosorbent assay; IFA; indirect immunofluorescence assay.